SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000819050-19-000030
Filing Date
2019-11-14
Accepted
2019-11-13 17:40:35
Documents
64
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a20190930-10q.htm   iXBRL 10-Q 1505926
2 EXHIBIT 31.1 ex311.htm EX-31.1 12823
3 EXHIBIT 31.2 ex312.htm EX-31.2 12482
4 EXHIBIT 32.1 ex321.htm EX-32.1 15463
  Complete submission text file 0000819050-19-000030.txt   6337453

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20190930.xsd EX-101.SCH 44970
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbi-20190930_cal.xml EX-101.CAL 63613
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbi-20190930_def.xml EX-101.DEF 221854
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20190930_lab.xml EX-101.LAB 591105
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20190930_pre.xml EX-101.PRE 351931
10 EXTRACTED XBRL INSTANCE DOCUMENT a20190930-10q_htm.xml XML 924809
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21088 | Film No.: 191215518
SIC: 2836 Biological Products, (No Diagnostic Substances)